The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study için istatistikler

Toplam ziyaret

views
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study 0

Aylık toplam ziyaret

views
Ağustos 2024 0
Eylül 2024 0
Ekim 2024 0
Kasım 2024 0
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0